ITMI20121109A1 - Composizione comprendente acido gascardico o un suo derivato e relativo uso come coadiuvante per antibiotici - Google Patents

Composizione comprendente acido gascardico o un suo derivato e relativo uso come coadiuvante per antibiotici Download PDF

Info

Publication number: ITMI20121109A1
Authority: IT; Italy
Prior art keywords: acid; derivatives; composition; gas; alternatively
Prior art date: 2012-06-25

Application number

IT001109A

Other languages

English (en)

Italian (it)

Inventor

Luigi Amelotti

Lorenzo Secondini

Original Assignee

Rode Pharma S R L

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-06-25

Filing date

2012-06-25

Publication date

2013-12-26

2012-06-25 Application filed by Rode Pharma S R L filed Critical Rode Pharma S R L

2012-06-25 Priority to IT001109A priority Critical patent/ITMI20121109A1/it

2013-06-25 Priority to EP13744788.4A priority patent/EP2863904B1/en

2013-06-25 Priority to CN201380042898.2A priority patent/CN104540503A/zh

2013-06-25 Priority to PCT/IB2013/001360 priority patent/WO2014001882A1/en

2013-06-25 Priority to US14/408,553 priority patent/US9775348B2/en

2013-06-25 Priority to IN2484MUN2014 priority patent/IN2014MN02484A/en

2013-12-26 Publication of ITMI20121109A1 publication Critical patent/ITMI20121109A1/it

Links

239000000203 mixture Substances 0.000 title claims description 55
JTMVWFPVJNHYAJ-UHFFFAOYSA-N Gascardic acid Natural products CC(CCC=C(C)C)C1CCC23CC=C(CCC2C(=C)CCC13C)C(=O)O JTMVWFPVJNHYAJ-UHFFFAOYSA-N 0.000 title claims description 36
239000003242 anti bacterial agent Substances 0.000 title claims description 34
229940088710 antibiotic agent Drugs 0.000 title claims description 27
230000003115 biocidal effect Effects 0.000 claims description 31
239000002253 acid Substances 0.000 claims description 26
241000894006 Bacteria Species 0.000 claims description 24
241000233866 Fungi Species 0.000 claims description 16
230000003385 bacteriostatic effect Effects 0.000 claims description 15
230000000844 anti-bacterial effect Effects 0.000 claims description 12
QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 claims description 11
CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 claims description 11
DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 claims description 11
QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 claims description 11
PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 claims description 11
MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 claims description 11
241000700605 Viruses Species 0.000 claims description 10
239000003814 drug Substances 0.000 claims description 10
230000000855 fungicidal effect Effects 0.000 claims description 10
239000000399 hydroalcoholic extract Substances 0.000 claims description 10
241001534869 Terminalia Species 0.000 claims description 9
230000001476 alcoholic effect Effects 0.000 claims description 7
239000012675 alcoholic extract Substances 0.000 claims description 7
238000000605 extraction Methods 0.000 claims description 7
150000007513 acids Chemical class 0.000 claims description 6
239000002671 adjuvant Substances 0.000 claims description 6
241000191967 Staphylococcus aureus Species 0.000 claims description 5
241000228212 Aspergillus Species 0.000 claims description 3
241000589516 Pseudomonas Species 0.000 claims description 3
241000589517 Pseudomonas aeruginosa Species 0.000 claims description 3
241000191940 Staphylococcus Species 0.000 claims description 3
241000228245 Aspergillus niger Species 0.000 claims description 2
241000193830 Bacillus <bacterium> Species 0.000 claims description 2
241000193755 Bacillus cereus Species 0.000 claims description 2
241000222122 Candida albicans Species 0.000 claims description 2
241000223259 Trichoderma Species 0.000 claims description 2
241000223261 Trichoderma viride Species 0.000 claims description 2
241000944294 Trichoderma viridescens Species 0.000 claims description 2
229940095731 candida albicans Drugs 0.000 claims description 2
241000894007 species Species 0.000 claims description 2
241000196324 Embryophyta Species 0.000 claims 1
244000292604 Salvia columbariae Species 0.000 claims 1
235000012377 Salvia columbariae var. columbariae Nutrition 0.000 claims 1
235000001498 Salvia hispanica Nutrition 0.000 claims 1
235000014167 chia Nutrition 0.000 claims 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
235000019441 ethanol Nutrition 0.000 description 14
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
238000012360 testing method Methods 0.000 description 12
150000001875 compounds Chemical class 0.000 description 9
235000009330 Terminalia Nutrition 0.000 description 8
230000000694 effects Effects 0.000 description 7
238000000034 method Methods 0.000 description 7
230000001580 bacterial effect Effects 0.000 description 6
239000002904 solvent Substances 0.000 description 6
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 5
229960003022 amoxicillin Drugs 0.000 description 5
LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 5
244000052616 bacterial pathogen Species 0.000 description 5
LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 5
239000000126 substance Substances 0.000 description 5
HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 description 4
241000192125 Firmicutes Species 0.000 description 4
229930182555 Penicillin Natural products 0.000 description 4
HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 description 4
229960003324 clavulanic acid Drugs 0.000 description 4
230000002401 inhibitory effect Effects 0.000 description 4
239000002054 inoculum Substances 0.000 description 4
239000000243 solution Substances 0.000 description 4
229930186147 Cephalosporin Natural products 0.000 description 3
241000588724 Escherichia coli Species 0.000 description 3
AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 3
244000100103 Terminalia arborea Species 0.000 description 3
244000125380 Terminalia tomentosa Species 0.000 description 3
239000006286 aqueous extract Substances 0.000 description 3
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
229940124587 cephalosporin Drugs 0.000 description 3
150000001780 cephalosporins Chemical class 0.000 description 3
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
125000001475 halogen functional group Chemical group 0.000 description 3
150000002960 penicillins Chemical class 0.000 description 3
239000008194 pharmaceutical composition Substances 0.000 description 3
239000000047 product Substances 0.000 description 3
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
239000013589 supplement Substances 0.000 description 3
FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 description 2
WZRJTRPJURQBRM-UHFFFAOYSA-N 4-amino-n-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1.COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 WZRJTRPJURQBRM-UHFFFAOYSA-N 0.000 description 2
235000003932 Betula Nutrition 0.000 description 2
241000219429 Betula Species 0.000 description 2
ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
241001360526 Escherichia coli ATCC 25922 Species 0.000 description 2
GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
241001103617 Pseudomonas aeruginosa ATCC 15442 Species 0.000 description 2
241001284285 Terminalia ivorensis Species 0.000 description 2
235000018723 Terminalia ivorensis Nutrition 0.000 description 2
239000004098 Tetracycline Substances 0.000 description 2
LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 2
229940126575 aminoglycoside Drugs 0.000 description 2
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
230000000843 anti-fungal effect Effects 0.000 description 2
239000003782 beta lactam antibiotic agent Substances 0.000 description 2
125000002619 bicyclic group Chemical group 0.000 description 2
OKBVVJOGVLARMR-QSWIMTSFSA-N cefixime Chemical compound S1C(N)=NC(C(=N\OCC(O)=O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 OKBVVJOGVLARMR-QSWIMTSFSA-N 0.000 description 2
235000005897 citrine myrobalan Nutrition 0.000 description 2
AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 description 2
229940047766 co-trimoxazole Drugs 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
239000000417 fungicide Substances 0.000 description 2
239000001963 growth medium Substances 0.000 description 2
239000007788 liquid Substances 0.000 description 2
239000003120 macrolide antibiotic agent Substances 0.000 description 2
229940041033 macrolides Drugs 0.000 description 2
239000000463 material Substances 0.000 description 2
239000002609 medium Substances 0.000 description 2
125000002950 monocyclic group Chemical group 0.000 description 2
FABPRXSRWADJSP-MEDUHNTESA-N moxifloxacin Chemical compound COC1=C(N2C[C@H]3NCCC[C@H]3C2)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 FABPRXSRWADJSP-MEDUHNTESA-N 0.000 description 2
229940056360 penicillin g Drugs 0.000 description 2
238000001243 protein synthesis Methods 0.000 description 2
229960001225 rifampicin Drugs 0.000 description 2
JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 2
WDZCUPBHRAEYDL-GZAUEHORSA-N rifapentine Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C(O)=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N(CC1)CCN1C1CCCC1 WDZCUPBHRAEYDL-GZAUEHORSA-N 0.000 description 2
239000007787 solid Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
235000019364 tetracycline Nutrition 0.000 description 2
150000003522 tetracyclines Chemical class 0.000 description 2
NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 2
230000014616 translation Effects 0.000 description 2
239000002132 β-lactam antibiotic Substances 0.000 description 2
229940124586 β-lactam antibiotics Drugs 0.000 description 2
DMDZKTYYUDNBKL-WCLWZXRXSA-N (2z,5e,9e)-2-[(e)-7-(furan-3-yl)-4-methylhept-4-enylidene]-11-methoxy-6,10-dimethyl-11-oxoundeca-5,9-dienoic acid Chemical compound COC(=O)C(\C)=C\CC\C(C)=C\CC\C(C(O)=O)=C\CC\C(C)=C\CCC=1C=COC=1 DMDZKTYYUDNBKL-WCLWZXRXSA-N 0.000 description 1
SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 1
UHHHTIKWXBRCLT-VDBOFHIQSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide;ethanol;hydrate;dihydrochloride Chemical compound O.Cl.Cl.CCO.C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O.C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O UHHHTIKWXBRCLT-VDBOFHIQSA-N 0.000 description 1
GOKZWKYAKOVREM-MAKIOEOWSA-N (5z)-5-[(e,2r)-9-[5-(furan-3-ylmethyl)furan-3-yl]-2,6-dimethylnon-6-enylidene]-4-hydroxy-3-methylfuran-2-one Chemical compound C([C@@H](C)\C=C/1C(=C(C)C(=O)O\1)O)CC\C(C)=C\CCC(C=1)=COC=1CC=1C=COC=1 GOKZWKYAKOVREM-MAKIOEOWSA-N 0.000 description 1
MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 description 1
RDYJVZDFWAUFPC-UHFFFAOYSA-N 19-bromo-15-thia-4,9,13-triazahexacyclo[12.6.1.13,7.01,16.02,12.010,22]docosa-2(12),3(22),5,7,9,19-hexaene-11,18-dione Chemical compound BrC1=CC23CC(Nc4c2c2[nH]ccc5cnc(c25)c4=O)SC3CC1=O RDYJVZDFWAUFPC-UHFFFAOYSA-N 0.000 description 1
WBLZUCOIBUDNBV-UHFFFAOYSA-N 3-nitropropanoic acid Chemical compound OC(=O)CC[N+]([O-])=O WBLZUCOIBUDNBV-UHFFFAOYSA-N 0.000 description 1
GOKZWKYAKOVREM-SFHVURJKSA-N 5-[9-(5-furan-3-ylmethyl-furan-3-yl)-2,6-dimethyl-non-6-enylidene]-4-hydroxy-3-methyl-5H-furan-2-one Natural products C[C@@H](CCCC(=CCCc1coc(Cc2cocc2)c1)C)C=C3/OC(=O)C(=C3O)C GOKZWKYAKOVREM-SFHVURJKSA-N 0.000 description 1
241000509040 Acidomyces acidophilus Species 0.000 description 1
241000203233 Aspergillus versicolor Species 0.000 description 1
108010001478 Bacitracin Proteins 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
235000009109 Betula pendula Nutrition 0.000 description 1
241000219430 Betula pendula Species 0.000 description 1
JFPVXVDWJQMJEE-QMTHXVAHSA-N Cefuroxime Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)C(=NOC)C1=CC=CO1 JFPVXVDWJQMJEE-QMTHXVAHSA-N 0.000 description 1
241000221032 Combretaceae Species 0.000 description 1
241000195493 Cryptophyta Species 0.000 description 1
KVSNMTUIMXZPLU-UHFFFAOYSA-N D:A-friedo-oleanane Natural products CC12CCC3(C)C4CC(C)(C)CCC4(C)CCC3(C)C2CCC2(C)C1CCCC2C KVSNMTUIMXZPLU-UHFFFAOYSA-N 0.000 description 1
MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 description 1
108010013198 Daptomycin Proteins 0.000 description 1
206010012735 Diarrhoea Diseases 0.000 description 1
241000266331 Eugenia Species 0.000 description 1
JUUHNUPNMCGYDT-UHFFFAOYSA-N Friedelin Natural products CC1CC2C(C)(CCC3(C)C4CC(C)(C)CCC4(C)CCC23C)C5CCC(=O)C(C)C15 JUUHNUPNMCGYDT-UHFFFAOYSA-N 0.000 description 1
UEPUJEQMUYSYHS-UHFFFAOYSA-N Furospongin 3 Natural products COC(=O)C(=CCCC(=CCCC(=CCCC(=CCCc1cocc1)C(=O)O)C)C)C UEPUJEQMUYSYHS-UHFFFAOYSA-N 0.000 description 1
239000005792 Geraniol Substances 0.000 description 1
GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
241000947583 Haslea ostrearia Species 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
NVFQZZXKGDYENB-UHFFFAOYSA-N Ircinin 1 Natural products CC(CCCC(=CCCc1cocc1Cc2cocc2)C)C=C3/OC(=O)C(=C3O)C NVFQZZXKGDYENB-UHFFFAOYSA-N 0.000 description 1
GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 description 1
241000555676 Malassezia Species 0.000 description 1
241001490848 Melia volkensii Species 0.000 description 1
229930193140 Neomycin Natural products 0.000 description 1
QSDSSSQWVNLFIG-UHFFFAOYSA-N Neosporin Natural products CC(O)CC1=C(OC)C(=O)C2=CC(O)=C3OCOC4=C(O)C=C5C6=C4C3=C2C1=C6C(CC(C)O)=C(OC)C5=O QSDSSSQWVNLFIG-UHFFFAOYSA-N 0.000 description 1
HFCDKJXZKWAPFG-UHFFFAOYSA-N Ophiobolin B Natural products CC(CCC=C(C)/C=O)C1(O)CCC2(C)CC3C(C(=CCC12)C)C(=O)CC3(C)O HFCDKJXZKWAPFG-UHFFFAOYSA-N 0.000 description 1
206010034133 Pathogen resistance Diseases 0.000 description 1
108010087702 Penicillinase Proteins 0.000 description 1
229930189077 Rifamycin Natural products 0.000 description 1
241000193998 Streptococcus pneumoniae Species 0.000 description 1
244000191422 Terminalia bellirica Species 0.000 description 1
241001610952 Terminalia brassii Species 0.000 description 1
241001610951 Terminalia brownii Species 0.000 description 1
235000019069 Terminalia brownii Nutrition 0.000 description 1
235000019071 Terminalia calamansanai Nutrition 0.000 description 1
241000045786 Terminalia calamansanay Species 0.000 description 1
241000001522 Terminalia chebula Species 0.000 description 1
235000011517 Terminalia chebula Nutrition 0.000 description 1
241001610945 Terminalia glaucescens Species 0.000 description 1
241001214690 Terminalia glaucifolia Species 0.000 description 1
240000000465 Terminalia microcarpa Species 0.000 description 1
235000007065 Terminalia oblongata Nutrition 0.000 description 1
235000017402 Terminalia oblongata subsp volucris Nutrition 0.000 description 1
235000005212 Terminalia tomentosa Nutrition 0.000 description 1
UTGBBPSEQPITLF-QMDQJFAJSA-N Terpestacin Chemical compound C1\C=C(C)/CC\C=C(C)/CC[C@H](O)\C(C)=C/C[C@@H]2C([C@@H](CO)C)=C(O)C(=O)[C@]21C UTGBBPSEQPITLF-QMDQJFAJSA-N 0.000 description 1
241000000714 Tritia reticulata Species 0.000 description 1
108010059993 Vancomycin Proteins 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
230000004075 alteration Effects 0.000 description 1
229960004821 amikacin Drugs 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
KLOHDWPABZXLGI-YWUHCJSESA-M ampicillin sodium Polymers [Na+].C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=CC=C1 KLOHDWPABZXLGI-YWUHCJSESA-M 0.000 description 1
230000000507 anthelmentic effect Effects 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
230000000840 anti-viral effect Effects 0.000 description 1
229940121375 antifungal agent Drugs 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
229940062316 avelox Drugs 0.000 description 1
MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 1
229960003071 bacitracin Drugs 0.000 description 1
229930184125 bacitracin Natural products 0.000 description 1
CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
229940098166 bactrim Drugs 0.000 description 1
229940087430 biaxin Drugs 0.000 description 1
229960004841 cefadroxil Drugs 0.000 description 1
NBFNMSULHIODTC-CYJZLJNKSA-N cefadroxil monohydrate Chemical compound O.C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=C(O)C=C1 NBFNMSULHIODTC-CYJZLJNKSA-N 0.000 description 1
229960002129 cefixime Drugs 0.000 description 1
229940106164 cephalexin Drugs 0.000 description 1
ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
AZFBLLCNOQPJGJ-DVAZEERGSA-N chembl1332607 Chemical compound O([C@](C1=O)(C)O\C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C\C=C(C)/C(=O)N2)C)OC)C(C(=C3O)C)=C1C(C1=N4)=C3C(O)=C2C1=NC14CCN(CC(C)C)CC1 AZFBLLCNOQPJGJ-DVAZEERGSA-N 0.000 description 1
-1 chloramphenyl Chemical compound 0.000 description 1
OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
229960001231 choline Drugs 0.000 description 1
MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 1
229960002626 clarithromycin Drugs 0.000 description 1
229960002227 clindamycin Drugs 0.000 description 1
KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
239000007799 cork Substances 0.000 description 1
229960000860 dapsone Drugs 0.000 description 1
229960005484 daptomycin Drugs 0.000 description 1
DOAKLVKFURWEDJ-QCMAZARJSA-N daptomycin Chemical compound C([C@H]1C(=O)O[C@H](C)[C@@H](C(NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@H](C(=O)N1)[C@H](C)CC(O)=O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CCCCCCCCC)C(=O)C1=CC=CC=C1N DOAKLVKFURWEDJ-QCMAZARJSA-N 0.000 description 1
230000007423 decrease Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
238000003113 dilution method Methods 0.000 description 1
XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
235000011180 diphosphates Nutrition 0.000 description 1
IWHQWCUADMOONN-UHFFFAOYSA-N discorhabdine C trifluoroacetic acid salt Natural products C1=C(Br)C(=O)C(Br)=CC11C(C=2C3=C(NC=C3CCN=2)C2=O)=C2NCC1 IWHQWCUADMOONN-UHFFFAOYSA-N 0.000 description 1
229960003722 doxycycline Drugs 0.000 description 1
229940079593 drug Drugs 0.000 description 1
108010046161 drug combination polymyxin B neomycin sulfate bacitracin zinc Proteins 0.000 description 1
229940099739 duricef Drugs 0.000 description 1
229960003276 erythromycin Drugs 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
239000000284 extract Substances 0.000 description 1
OFMXGFHWLZPCFL-SVRPQWSVSA-N friedelin Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3CCC(=O)[C@@H]1C OFMXGFHWLZPCFL-SVRPQWSVSA-N 0.000 description 1
MFVJCHSUSSRHRH-UHFFFAOYSA-N friedeline Natural products CC1(C)CCC2(C)CCC3C4(C)CCC5C(C)(C)C(=O)CCC5(C)C4CCC3(C)C2C1 MFVJCHSUSSRHRH-UHFFFAOYSA-N 0.000 description 1
AJMWIYWHXKOBKT-UHFFFAOYSA-N genepolide Natural products CC(=CCCC1=CCC2(CC1)C3CCC(=CCCC(=CC3OC2=O)C)C)C AJMWIYWHXKOBKT-UHFFFAOYSA-N 0.000 description 1
229940113087 geraniol Drugs 0.000 description 1
125000002350 geranyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
235000005898 kalumpit Nutrition 0.000 description 1
239000002207 metabolite Substances 0.000 description 1
229940110254 minocin Drugs 0.000 description 1
229960004023 minocycline Drugs 0.000 description 1
229960003702 moxifloxacin Drugs 0.000 description 1
229960003128 mupirocin Drugs 0.000 description 1
229930187697 mupirocin Natural products 0.000 description 1
DDHVILIIHBIMQU-YJGQQKNPSA-L mupirocin calcium hydrate Chemical compound O.O.[Ca+2].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1.C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1 DDHVILIIHBIMQU-YJGQQKNPSA-L 0.000 description 1
239000005445 natural material Substances 0.000 description 1
229960004927 neomycin Drugs 0.000 description 1
229940049337 neosporin Drugs 0.000 description 1
MWYYLZRWWNBROW-BDZRSQQBSA-N ophiobolin A Chemical compound C[C@H]1C[C@H](C=C(C)C)O[C@]11[C@@H]2C\C=C(C=O)/[C@@H](C(=O)C[C@@]3(C)O)[C@@H]3C[C@@]2(C)CC1 MWYYLZRWWNBROW-BDZRSQQBSA-N 0.000 description 1
SXRLPRKYTRWOES-PCQMDVLKSA-N ophiobolin b Chemical compound O=CC/1=C/C[C@H]2[C@]([C@H](CCC=C(C)C)C)(O)CC[C@]2(C)C[C@@H]2[C@@](O)(C)CC(=O)[C@@H]2\1 SXRLPRKYTRWOES-PCQMDVLKSA-N 0.000 description 1
SXRLPRKYTRWOES-UHFFFAOYSA-N orphiobolin B Natural products O=CC1=CCC2C(C(CCC=C(C)C)C)(O)CCC2(C)CC2C(O)(C)CC(=O)C21 SXRLPRKYTRWOES-UHFFFAOYSA-N 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
235000019371 penicillin G benzathine Nutrition 0.000 description 1
229950009506 penicillinase Drugs 0.000 description 1
229930001119 polyketide Natural products 0.000 description 1
150000003881 polyketide derivatives Chemical class 0.000 description 1
239000002243 precursor Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
CMAYFTLWMPBENG-UHFFFAOYSA-N prianosine B Natural products C1=CC2=CNC(C(C=3NC4CC5(C=33)C=C(C(CC5S4)=O)Br)=O)=C2C3=N1 CMAYFTLWMPBENG-UHFFFAOYSA-N 0.000 description 1
229940087661 priftin Drugs 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
230000011514 reflex Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
BTVYFIMKUHNOBZ-QXMMDKDBSA-N rifamycin s Chemical class O=C1C(C(O)=C2C)=C3C(=O)C=C1NC(=O)\C(C)=C/C=C\C(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)\C=C/OC1(C)OC2=C3C1=O BTVYFIMKUHNOBZ-QXMMDKDBSA-N 0.000 description 1
229940081192 rifamycins Drugs 0.000 description 1
229960002599 rifapentine Drugs 0.000 description 1
229940048278 septra Drugs 0.000 description 1
238000013207 serial dilution Methods 0.000 description 1
UTGBBPSEQPITLF-UHFFFAOYSA-N siccanol Natural products C1C=C(C)CCC=C(C)CCC(O)C(C)=CCC2C(C(CO)C)=C(O)C(=O)C21C UTGBBPSEQPITLF-UHFFFAOYSA-N 0.000 description 1
ORVLUIMCZUPAPB-LBTQIPEASA-M sodium (4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide dioxido(oxo)phosphanium phosphenic acid Chemical compound [Na+].O[P+]([O-])=O.O[P+]([O-])=O.O[P+]([O-])=O.O[P+]([O-])=O.O[P+]([O-])=O.[O-][P+]([O-])=O.CN(C)[C@H]1[C@@H]2C[C@H]3C(=C(O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(O)=C(C(N)=O)C1=O.CN(C)[C@H]1[C@@H]2C[C@H]3C(=C(O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(O)=C(C(N)=O)C1=O.CN(C)[C@H]1[C@@H]2C[C@H]3C(=C(O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(O)=C(C(N)=O)C1=O.CN(C)[C@H]1[C@@H]2C[C@H]3C(=C(O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(O)=C(C(N)=O)C1=O.CN(C)[C@H]1[C@@H]2C[C@H]3C(=C(O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(O)=C(C(N)=O)C1=O ORVLUIMCZUPAPB-LBTQIPEASA-M 0.000 description 1
238000009331 sowing Methods 0.000 description 1
238000002798 spectrophotometry method Methods 0.000 description 1
229940031000 streptococcus pneumoniae Drugs 0.000 description 1
239000000758 substrate Substances 0.000 description 1
229940035786 sulfatrim Drugs 0.000 description 1
229940072176 sulfonamides and trimethoprim antibacterials for systemic use Drugs 0.000 description 1
JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
229940072226 suprax Drugs 0.000 description 1
235000007954 swamp oak Nutrition 0.000 description 1
230000002195 synergetic effect Effects 0.000 description 1
150000003505 terpenes Chemical class 0.000 description 1
235000007586 terpenes Nutrition 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
229940040944 tetracyclines Drugs 0.000 description 1
229960000707 tobramycin Drugs 0.000 description 1
229940035275 tobrex Drugs 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
150000003648 triterpenes Chemical class 0.000 description 1
239000006150 trypticase soy agar Substances 0.000 description 1
229960003165 vancomycin Drugs 0.000 description 1
MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
229940063678 vibramycin Drugs 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing carboxylic groups or thio analogues thereof, directly attached by the carbon atom to a cycloaliphatic ring; Derivatives thereof
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
- A01N35/06—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing keto or thioketo groups as part of a ring, e.g. cyclohexanone, quinone; Derivatives thereof, e.g. ketals
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
- A01N43/647—Triazoles; Hydrogenated triazoles
- A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Wood Science & Technology (AREA)
Environmental Sciences (AREA)
Zoology (AREA)
Dentistry (AREA)
Engineering & Computer Science (AREA)
Plant Pathology (AREA)
Agronomy & Crop Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pest Control & Pesticides (AREA)
Virology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

IT001109A 2012-06-25 2012-06-25 Composizione comprendente acido gascardico o un suo derivato e relativo uso come coadiuvante per antibiotici ITMI20121109A1 (it)

Priority Applications (6)

Application Number	Priority Date	Filing Date	Title
IT001109A ITMI20121109A1 (it)	2012-06-25	2012-06-25	Composizione comprendente acido gascardico o un suo derivato e relativo uso come coadiuvante per antibiotici
EP13744788.4A EP2863904B1 (en)	2012-06-25	2013-06-25	Use of gascardic acid as antibiotic and antifungal adjuvant
CN201380042898.2A CN104540503A (zh)	2012-06-25	2013-06-25	包括二倍半萜的组合物及其作为抗生素佐剂和抗真菌剂佐剂的用途
PCT/IB2013/001360 WO2014001882A1 (en)	2012-06-25	2013-06-25	Composition comprising a sesterterpene and use thereof as antibiotic and antifungal adjuvant
US14/408,553 US9775348B2 (en)	2012-06-25	2013-06-25	Composition comprising a sesterterpene and use thereof as antibiotic and antifungal adjuvant
IN2484MUN2014 IN2014MN02484A (2)	2012-06-25	2013-06-25

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT001109A ITMI20121109A1 (it)	2012-06-25	2012-06-25	Composizione comprendente acido gascardico o un suo derivato e relativo uso come coadiuvante per antibiotici

Publications (1)

Publication Number	Publication Date
ITMI20121109A1 true ITMI20121109A1 (it)	2013-12-26

Family

ID=46690597

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IT001109A ITMI20121109A1 (it)	2012-06-25	2012-06-25	Composizione comprendente acido gascardico o un suo derivato e relativo uso come coadiuvante per antibiotici

Country Status (6)

Country	Link
US (1)	US9775348B2 (2)
EP (1)	EP2863904B1 (2)
CN (1)	CN104540503A (2)
IN (1)	IN2014MN02484A (2)
IT (1)	ITMI20121109A1 (2)
WO (1)	WO2014001882A1 (2)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN104940211B (zh) *	2015-06-08	2018-06-19	广州万粤知识产权运营有限公司	白桦脂酸在制备抗真菌生物被膜药物中的应用
CN108516923B (zh) *	2018-05-22	2019-06-25	天津汉荣生物技术有限公司	一系列烯萜类化合物及其制备方法和应用
US12171748B2 (en)	2018-05-29	2024-12-24	IRP Health Pty Ltd	Nitroimidazole formulations
CN109662967B (zh) *	2019-02-19	2021-02-12	孙益虎	一种抗抑郁药物及其用途
CN110507660A (zh) *	2019-09-24	2019-11-29	吉林大学	五环三萜类化合物在制备细菌性溶血素抑制剂中的用途
CN111658683A (zh) *	2020-05-15	2020-09-15	广东药科大学	诃子提取物在制备马拉色菌抑制剂中的应用
CN114224876B (zh) *	2021-11-03	2023-04-07	中南民族大学	二倍半萜类化合物的制备方法及其在抗临床耐药细菌方面的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5270344A (en) *	1988-06-24	1993-12-14	Stephen Herman	Method of treating a systemic disorder using trioxolane and diperoxide compounds
US5190979A (en) *	1988-06-24	1993-03-02	Stephen Herman	Ozonides of terpenes and their medical uses
JP2004509972A (ja) *	2000-09-29	2004-04-02	リージェンツ　オブ　ザ　ユニバーシティ　オブ　ミネソタ	酵母に対する殺真菌活性を有するトリテルペン

2012
- 2012-06-25 IT IT001109A patent/ITMI20121109A1/it unknown
2013
- 2013-06-25 EP EP13744788.4A patent/EP2863904B1/en not_active Not-in-force
- 2013-06-25 WO PCT/IB2013/001360 patent/WO2014001882A1/en not_active Ceased
- 2013-06-25 CN CN201380042898.2A patent/CN104540503A/zh active Pending
- 2013-06-25 IN IN2484MUN2014 patent/IN2014MN02484A/en unknown
- 2013-06-25 US US14/408,553 patent/US9775348B2/en not_active Expired - Fee Related

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BAAS ET AL: "Naturally occurring seco-ring-A-triterpenoids and their possible biological significance", PHYTOCHEMISTRY, PERGAMON PRESS, GB, vol. 24, no. 9, 1 January 1985 (1985-01-01), pages 1875 - 1889, XP026617013, ISSN: 0031-9422, [retrieved on 19850101], DOI: 10.1016/S0031-9422(00)83085-X *
BOECKMAN ROBERT K JR ET AL: "A total synthesis of gascardic acid", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, ACS PUBLICATIONS, US, vol. 101, no. 17, 1 August 1979 (1979-08-01), pages 5060 - 5062, XP009163435, ISSN: 0002-7863 *
FLEKHTER O B ET AL: "Synthesis of betulinic acid from betulin extract and study of the antiviral and antiulcer activity of some related terpenoids", PHARMACEUTICAL CHEMISTRY JOURNAL 20020901 US LNKD- DOI:10.1023/A:1021844705853, vol. 36, no. 9, 1 September 2002 (2002-09-01), pages 484 - 487, XP002684912, ISSN: 0091-150X *
LIU M ET AL: "Phytochemical and antifungal studies on Terminalia mollis and Terminalia brachystemma", FITOTERAPIA, IDB HOLDING, MILAN, IT, vol. 80, no. 6, 1 September 2009 (2009-09-01), pages 369 - 373, XP026319368, ISSN: 0367-326X, [retrieved on 20090514], DOI: 10.1016/J.FITOTE.2009.05.006 *

Also Published As

Publication number	Publication date
CN104540503A (zh)	2015-04-22
IN2014MN02484A (2)	2015-07-10
US9775348B2 (en)	2017-10-03
WO2014001882A1 (en)	2014-01-03
US20150196029A1 (en)	2015-07-16
EP2863904A1 (en)	2015-04-29
EP2863904B1 (en)	2018-02-21

Publication	Publication Date	Title
Tamokou et al.	2012	Antioxidant and antimicrobial activities of ethyl acetate extract, fractions and compounds from stem bark of Albizia adianthifolia (Mimosoideae)
Jang et al.	2014	Combination effects of baicalein with antibiotics against oral pathogens
US9775348B2 (en)	2017-10-03	Composition comprising a sesterterpene and use thereof as antibiotic and antifungal adjuvant
Mathur et al.	2010	Pharmacological investigation of Bacopa monnieri on the basis of antioxidant, antimicrobial and anti-inflammatory properties
Arif et al.	2009	In vitro and in vivo antimicrobial activities of seeds of Caesalpinia bonduc (Lin.) Roxb.
Liu et al.	2019	Antibacterial and antibiotic synergistic activities of the extract from Pithecellobium clypearia against clinically important multidrug-resistant gram-negative bacteria
Harfouch et al.	2016	Antibacterial activity of Syrian propolis extract against several strains of bacteria in vitro
Espanha et al.	2014	Mutagenicity and antimutagenicity of six Brazilian Byrsonima species assessed by the Ames test
do Socorro Costa et al.	2022	Evaluation of the antibacterial and inhibitory activity of NorA and MepA efflux pumps from Staphylococcus aureus by diosgenin
Nwaokorie et al.	2010	Antimicrobial activities of Garcinia kola on oral Fusobacterium nucleatum and biofilm
Kandpal et al.	2016	Evaluation of antibiotic and biochemical potential of bryophytes from kumaun hills and tarai belt of himalayas
Yahiaoui et al.	2017	Antibacterial activity of mentha pulegiumessential oil against avian isolated esbl producing bacteria and its synergistic potential with antibiotics
Oliveira-Júnior et al.	2012	Phytochemical screening, antioxidant and antibacterial activity of extracts from the flowers of Neoglaziovia variegata (Bromeliaceae)
Nguelefack et al.	2005	Phytochemical composition and in vitro effects of the ethyl acetate bark extract of Distemonanthus benthamianus Baillon (Caesalpiniaceae) on Staphylococcus aureus and Streptococcus agalactiae
Penduka et al.	2015	THE ANTIBACTERIAL ACTIVITIES OF SOME PLANT DERIVED TRITERPENES
Khan et al.	2016	Antibacterial activity of Rhazya stricta non-alkaloid extract against methicillin-resistant Staphylococcus aureus
Yolanda et al.	2024	Study of binahong leaves (anredera cordifolia (ten.) steenis) potency as an herbal feed additive for lactating dairy animals
Pandey et al.	2016	Evaluation of anthelmintic and antimicrobial activity of ursolic acid obtained from Tulsi (Ocimum sanctum)
Reddy et al.	2013	Evaluation of antibacterial and DPPH radical scavenging activities of the leaf extracts and leaf essential oil of Syzygium cumini Linn. from South India
Satoh et al.	2025	Characterization of the anti-Porphyromonas gingivalis compound in bilberry (Vaccinium myrtillus L.) and comparison with its analogs
Saral et al.	2019	Antibacterial activity of DMSO extracts of selected plants against antibiotic resistant clinical isolates
Shwaish et al.	2023	Antibacterial activity of Syzygium aromaticum against Klebsiella pneumoniae and Staphylococcus aureus isolated from urinary tract of dogs
Kukla et al.	2014	IN VITRO ANTIBACTERIAL ACTIVITY OF USNIC ACID AND OCTYL GALLATE AGAINST RESISTANT ENTEROCOCCUS STRAINS
Zare	2021	Investigating of Anti-bacterial and Anti-fungal Activities of Lantana camara L. Against Human Pathogens
Sharma et al.	2024	COMPARATIVE ANALYSIS OF ANTIOXIDANT AND ANTIBACTERIAL ACTIVITY OF AQUEOUS EXTRACT OF LEAF, BARK, FLOWER AND FRUIT PULP OF CASSIA FISTULA.